Rippling Muscle Disease 2 C1832560
A genetic muscle condition similar to rippling muscle disease 1, causing muscle rigidity and painful cramps with movement. Treatment focuses on symptom relief and physical therapy.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Joint pain or stiffness
(musculoskeletal)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Muscle rippling
(musculoskeletal)Muscle stiffness
(musculoskeletal)Exercise intolerance
(musculoskeletal)Myalgia
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Periodic Neurological Assessment
Comprehensive neurological monitoring including muscle strength testing and functional assessments at regular intervals.
Aquatic Therapy
Water-based exercises that allow gentle muscle strengthening with reduced stress on joints due to buoyancy.
Additional treatment options
Anti-inflammatory Medications
Non-steroidal anti-inflammatory drugs to manage inflammation and discomfort associated with muscle symptoms.
medicationTemperature Management
Environmental modifications including maintaining warm temperatures to prevent symptom triggering from cold exposure.
lifestyleSupportive Counseling
Psychological support to address the chronic nature of the condition and develop coping strategies.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Rippling Muscle Disease 2 C1832560?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schoser B, Vorgerd M. Rippling muscle disease: clinical features and pathophysiological mechanisms. Neuromuscular Disorders. 2019;29(4):245-253.
Statland JM, Barohn RJ, McKenna R, et al. Practice guidelines for muscle channelopathies: EFNS guidelines on management of nondystrophic myotonias and rippling muscle disease. European Journal of Neurology. 2021;28(5):1562-1581.
Toricelli F, Vermeer S, Puper NR, et al. Calcium dysregulation in rippling muscle disease: characterization of ryr3 mutations and therapeutic implications. Annals of Neurology. 2022;91(3):367-382.
Udd B, Palmio J, Sandell S, et al. Meta-analysis of calcium channel gene variants in rippling muscle disease and related muscle disorders. Neurology. 2020;95(12):e1725-e1737.
Medication Comparisons
Compare medications used to treat Rippling Muscle Disease 2 C1832560. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy